Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder

NCT03902613 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT03902613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03902613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Completed
Start date
February 7, 2019
Completion date
August 1, 2019
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression